This Webinar will detail the benefits MALDI TOF technology can add to your QC- or R/D-analytical lab for analyzing polymer samples. More structural information can be retrieved from your samples when ...
The Medical City South Luzon (TMCSL) introduces MALDITOF Mass Spectrometry, becoming the first hospital in the region to offer this technology. MALDI-TOF gives physicians a faster, more precise tool ...
Boston-based PerkinElmer Life and Analytical Sciences has released the prOTOF™ 2000, the first commercially available matrix-assisted laser desorption/ionization-time of flight (MALDI-TOF) mass ...
MALDI-TOF mass spectrometry is a diagnostic tool of microbial identification and characterization based on the detection of the mass of molecules. In the majority of clinical laboratories, this ...
Until recently, clinical diagnostic laboratories predominantly relied on conventional phenotypic ways of diagnosing infections, and sometimes on gene sequencing techniques. The latest advancements in ...
Bruker Corporation BRKR recently announced the launch of the neofleX Imaging Profiler for mass spectrometry-based tissue imaging at the 72nd ASMS meeting. The novel, high-performance MALDI-TOF/TOF ...
Clinical applications for mass spectrometry technology have exploded in recent years. Mass spectrometry analysis is often faster, cheaper, and more sensitive than other methods and is thus ideally ...
MALDI Biotyper-based microbial identification has major advantages compared to classical automated biochemical testing, including faster time to result (TTR) and better information with deeper and ...
A new technology, called MALDI-TOF MS, that identifies bacteria and fungi in patient specimens, is more efficient and cost-effective than conventional methods, according to a study by researchers at ...
Dr. Markus Kostrzewa will elaborate on the progress that has been made in Bruker Microbiology & Diagnostics, specifically on the innovation and evolution of the FDA-cleared MALDI Biotyper ® CA System.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results